358 related articles for article (PubMed ID: 29667048)
21. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.
Slobbe L; Doorduijn JK; Lugtenburg PJ; El Barzouhi A; Boersma E; van Leeuwen WB; Rijnders BJ
PLoS One; 2010 May; 5(5):e10840. PubMed ID: 20520776
[TBL] [Abstract][Full Text] [Related]
22. Central catheter-associated bloodstream infection reduction with ethanol lock prophylaxis in pediatric intestinal failure: broadening quality improvement initiatives from hospital to home.
Ardura MI; Lewis J; Tansmore JL; Harp PL; Dienhart MC; Balint JP
JAMA Pediatr; 2015 Apr; 169(4):324-31. PubMed ID: 25642912
[TBL] [Abstract][Full Text] [Related]
23. What is the best catheter lock solution in preventing catheter-related blood infections? A protocol for a Bayesian network meta-analysis of randomised controlled trials.
Dang F; Li H; Tian J; Wang R; Ren J
BMJ Open; 2019 Jun; 9(6):e030019. PubMed ID: 31256039
[TBL] [Abstract][Full Text] [Related]
24. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review.
Huang EY; Chen C; Abdullah F; Aspelund G; Barnhart DC; Calkins CM; Cowles RA; Downard CD; Goldin AB; Lee SL; St Peter SD; Arca MJ;
J Pediatr Surg; 2011 Oct; 46(10):2000-11. PubMed ID: 22008341
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.
Schoot RA; van Dalen EC; van Ommen CH; van de Wetering MD
Cochrane Database Syst Rev; 2013 Jun; (6):CD008975. PubMed ID: 23799867
[TBL] [Abstract][Full Text] [Related]
26. Salvage of infected tunneled hemodialysis catheters using 70% ethanol lock solution: A brief report.
Visweswaran K; Ravi R; Daniel David J; Krishnaswamy S; Akhil R
Hemodial Int; 2022 Jul; 26(3):E22-E26. PubMed ID: 34907637
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review and Meta-Analysis of Antibiotic and Antimicrobial Lock Solutions for Prevention of Hemodialysis Catheter-Related Infections.
Abdul Salim S; Masoud AT; Thongprayoon C; Cheungpasitporn W; Soliman KM; Garla V; Sofy AA; Ahmed AS; Abdelsattar AT; Zsom L; Tapolyai M; Fülöp T
ASAIO J; 2021 Oct; 67(10):1079-1086. PubMed ID: 33587469
[TBL] [Abstract][Full Text] [Related]
28. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
Neusser MA; Bobe I; Hammermeister A; Wittmann U
Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.
Arechabala MC; Catoni MI; Claro JC; Rojas NP; Rubio ME; Calvo MA; Letelier LM
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010597. PubMed ID: 29611180
[TBL] [Abstract][Full Text] [Related]
30. Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis.
Zhang J; Wang B; Li R; Ge L; Chen KH; Tian J
Int Urol Nephrol; 2017 Apr; 49(4):701-716. PubMed ID: 28035620
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of ethanol locks to reduce the incidence of catheter-related bloodstream infections for home parenteral nutrition pediatric patients: comparison of therapeutic treatment with prophylactic treatment.
Kawano T; Kaji T; Onishi S; Yamada K; Yamada W; Nakame K; Mukai M; Ieiri S
Pediatr Surg Int; 2016 Sep; 32(9):863-7. PubMed ID: 27461433
[TBL] [Abstract][Full Text] [Related]
32. Ethanol lock therapy in pediatric patients: A multicenter prospective study.
Chiba M; Yonekura T; Kaji T; Amae S; Tazuke Y; Oowari M; Obana K; Nakano M; Kuroda T; Fukumoto K; Yamane Y; Yoshino H; Hebiguchi T; Toki A
Pediatr Int; 2020 Mar; 62(3):379-385. PubMed ID: 31840325
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials.
Yahav D; Rozen-Zvi B; Gafter-Gvili A; Leibovici L; Gafter U; Paul M
Clin Infect Dis; 2008 Jul; 47(1):83-93. PubMed ID: 18498236
[TBL] [Abstract][Full Text] [Related]
34. Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
Souweine B; Lautrette A; Gruson D; Canet E; Klouche K; Argaud L; Bohe J; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Cointault O; Lepape A; Guelon D; Darmon M; Vesin A; Caillot N; Schwebel C; Boyer A; Azoulay E; Bouadma L; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(9):1024-32. PubMed ID: 25668557
[TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
[TBL] [Abstract][Full Text] [Related]
36. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
37. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Gudiol C; Arnan M; Aguilar-Guisado M; Royo-Cebrecos C; Sánchez-Ortega I; Montero I; Martín-Gandul C; Laporte-Amargós J; Albasanz-Puig A; Nicolae S; Perayre M; Berbel D; Tebe C; Riera J; Sureda A; Cisneros JM; Carratalà J
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712211
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection.
Zanwar S; Jain P; Gokarn A; Devadas SK; Punatar S; Khurana S; Bonda A; Pruthy R; Bhat V; Qureshi S; Khattry N
Transpl Infect Dis; 2019 Feb; 21(1):e13017. PubMed ID: 30369006
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes associated with the use of the NexSite hemodialysis catheter with new exit barrier technology: Results from a prospective, observational multi-center registry study.
Hoggard JG; Blair RD; Montero M; Moustafa MA; Newman J; Pergola PE; Saucier N; Wheeler CJ; Mermel LA; Ross JR; Beserab AD
PLoS One; 2019; 14(10):e0223285. PubMed ID: 31589644
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of 13 antimicrobial dressings and different securement devices in reducing catheter-related bloodstream infections: A Bayesian network meta-analysis.
Dang FP; Li HJ; Tian JH
Medicine (Baltimore); 2019 Apr; 98(14):e14940. PubMed ID: 30946317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
